Literature DB >> 20703885

Benefit from jejunal levodopa in a patient with apomorphine pump.

Fabian Klostermann, Constanze Jugel, Frank Marzinzik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20703885     DOI： 10.1007/s00415-010-5698-x

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.

Authors:  D Nyholm; A I M Nilsson Remahl; N Dizdar; R Constantinescu; B Holmberg; R Jansson; S-M Aquilonius; H Askmark
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

2.  Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.

Authors:  Holger Honig; Angelo Antonini; Pablo Martinez-Martin; Ian Forgacs; Guy C Faye; Thomas Fox; Karen Fox; Francesca Mancini; Margherita Canesi; Per Odin; K Ray Chaudhuri
Journal:  Mov Disord       Date:  2009-07-30       Impact factor: 10.338

3.  On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients.

Authors:  I Shoulson; G A Glaubiger; T N Chase
Journal:  Neurology       Date:  1975-12       Impact factor: 9.910

4.  Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations.

Authors:  D Nyholm; R Constantinescu; B Holmberg; N Dizdar; H Askmark
Journal:  Acta Neurol Scand       Date:  2008-09-25       Impact factor: 3.209

5.  Continuous dopaminergic stimulation achieved by duodenal levodopa infusion.

Authors:  Per Odin; Erik Wolters; Angelo Antonini
Journal:  Neurol Sci       Date:  2008-12       Impact factor: 3.307

6.  Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.

Authors:  Angelo Antonini; Ioannis U Isaias; Margherita Canesi; Maurizio Zibetti; Francesca Mancini; Luigi Manfredi; Marco Dal Fante; Leonardo Lopiano; Gianni Pezzoli
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

7.  Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.

Authors:  David Devos
Journal:  Mov Disord       Date:  2009-05-15       Impact factor: 10.338
  7 in total
  1 in total

Review 1.  Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

Authors:  Maria José Catalán; Angelo Antonini; Matilde Calopa; Ovidiu Băjenaru; Oriol de Fábregues; Adolfo Mínguez-Castellanos; Per Odin; José Manuel García-Moreno; Stephen W Pedersen; Zvezdan Pirtošek; Jaime Kulisevsky
Journal:  eNeurologicalSci       Date:  2017-07-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.